Skip to main content


Acting FTC chairman says deal with China with carrots and sticks

Acting FTC Chair Maureen Ohlhausen says the U.S. has to point out the bad and recognize the good in antitrust issues with China.

Shire Rejects $46B AbbVie Offer

The proposal followed two other pitches from AbbVie, which wants to move its tax domicile to the U.K.

Shire Quickly Pulls Off Dermagraft

Irish pharmaceuticals company Shire said on Friday it had arranged to hand its Dermagraft skin substitute to Organogenesis and take a $650 million loss on the disposal, which unwinds a major part of an acquisition it made less than three years ago.

Market Up on Deals, Results

Markets edged higher as some stocks jumped on deal making, with key retailer results to be closely watched this week.

Shire Deal Just The Start

Shire's purchase of ViroPharma is a signal of deals and higher prices ahead, says Jason Kolbert, Sr. Research Analyst at the Maxim Group.

Breaking News

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.